ARCT

Conviction 5HealthcareScan · Thu, Jun 25, 2026

ARCT$6.82-2.71%

ResistanceSupportVol 14

Vol MA14 344.42K

Mar 26Apr 14May 1May 19Jun 8Jun 25

Arcturus Therapeutics Holdings Inc.PHARMACEUTICAL PREPARATIONSwww.arcturusrx.com ↗

Price6.82

Change-2.71%

Gap+0.57%

Rel volume1.03×

Avg volume378.3K

Avg $ vol2.8M

SMA 207.34

SMA 507.87

SMA 2009.56

Price vs 50-13.34%

Price vs 200-28.65%

MA stackbearish

50/200 cross—

Supertrenddown · 8.28

RSI (14)40

MACD hist-0.01

MACD crossbear · 0d

Stoch %K / %D8 / 18

ADX (14)17

+DI / −DI16 / 23

RSI divergence—

MACD divergence—

ATR %+6.68%

ADR %5.70%

52w high23.16

52w low5.90

From 52w high-70.55%

Above 52w low+15.59%

New 52w highNo

SqueezeOff

Bollinger width19.67%

%B0.14

Donchian pos7.43%

Donchian high8.19

Donchian low6.71

AVWAP (52w high)8.60

vs AVWAP high-20.66%

AVWAP (52w low)7.34

vs AVWAP low-7.08%

OBV trendDown

Chaikin MF (20)-0.15

Today vs 20d1.03×

Avg vol (14d)344.42K

Avg vol (20d)378.3K

Avg $ vol (20d)2.8M

Market cap193.85M

RS 3m (vs SPY)-6.84%

RS 6m (vs SPY)-0.39%

RS line new highNo

Trend template0/8

Technical rank27.7

1 week-7.34%

1 month-5.41%

3 months-3.40%

6 months+3.49%

1 year-49.14%

YTD+9.12%

P/E-2.95

P/B1.01

P/S2.36

P/FCF-2.60

EPS-2.40

Div yield—

ROE-34.38%

ROA-26.81%

Debt/Eq0.40

Current6.31

EV/EBITDA-0.79

Gross margin—

Net margin-80.19%

Rev growth-46.14%

EPS growth18.73%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value58.13M

Revenue2.06M

Net income-26.96M

Gross profit—

Free cash flow-74.5M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out28.42M

Employees111

ListedWed, May 22, 2013

Free float23.77M

Float %83.6%

Short interest6.73M

Days to cover16.4d

Short volume53.5%

Squeeze score75 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction5 / 100

Pattern quality—

Tech rank27.7 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance8.89

Support6.69

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ARCT

All disclosures →

No recent disclosed trades by Congress in ARCT. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ARCT · 1 buy

Insider	Side	Shares	Value	Traded	Filed
MULROY DENNIS Chief Financial Officer · Employee Stock Option (right to buy) · 2026-05-01	Grant	100K	$0	2026-05-01	2026-05-07

SEC filings

EDGAR filings in ARCT · 1 recent

EDGAR →

8-K8-KFri, Jun 5, 2026

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.